Clinical Trial Update: Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and efficacy of toripalimab in locally advanced or metastatic bladder urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Bladder Urothelial Carcinoma | Phase 2 | Status: UNKNOWN